Anti-MERS-CoV Spike Protein Reference Antibody (3A1)

Description: Anti-MERS-CoV Spike Protein Antibody (3A1) (BS12416) is a research-grade recombinant antibody targeting Spike glycoprotein. Produced in mammalian cells with native-like glycosylation.
Highlights:
• Research Grade — For PK/PD studies, assay development, and ADA research.
• Native Glycosylation — Mammalian expression ensures native-like patterns.
Host species: Human
Isotype: IgG
Species reactivity: MiddleEastrespiratorysyndrome-relatedcoronavirus(isolateUnitedKingdom/H123990006/2012)(MERS-CoV)(BetacoronavirusEngland1)
Immunogen:
Form: Liquid
Storage instructions:
Storage buffer: 0.01M PBS, pH7.4.
Concentration: 1mg/ml
Purity: >95% as determined by SDS-PAGE.
Clonality:
Applications: Research Grade Biosimilar
Target: Spikeglycoprotein,Sglycoprotein,E2,Peplomerprotein,SpikeproteinS1,SpikeproteinS2,SpikeproteinS2',S,3
Purification: Protein A/G purified from cell culture supernatant.
Endotoxin level: <1EU/mg, determined by LAL gel clotting assay
Expression system: Mammalian Cells
Stability and Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names:
Background: Spike glycoprotein is a ~149 kDa protein. Attaches the virion to the cell membrane by interacting with host receptor, initiating the infection. Interacts with host DPP4 to mediate virla entry.
Note: For research use only. Not suitable for clinical or therapeutic use.